{
    "success": true,
    "data": {
        "leverage": true,
        "derivates": true,
        "swaps": false,
        "inverse": true,
        "replication_method": "synthetic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Leverage (5x daily)",
            "Inverse exposure",
            "Derivative-based strategy (FX Forwards)",
            "Daily compounding risk"
        ],
        "classification": "complex",
        "supporting_data": "The product is classified as complex based on several definitive factors. Firstly, it employs 5x daily leverage and provides inverse exposure ('Short USD'), which are inherently complex mechanisms. The strategy relies entirely on derivatives (FX forward contracts) to achieve its investment objective, which is not for efficient portfolio management but is central to the product's function. The Key Information Document (KID) explicitly warns about the daily compounding effect, stating that for periods longer than one day, the return is not simply -5x the index performance, a concept that is difficult for retail investors to grasp. The document also highlights the effect of 'rolling' forward contracts, which introduces complex risks like roll costs. Furthermore, the product is an Exchange Traded Product (ETP) structured as a collateralised debt security, not a UCITS fund, so the presumption of non-complexity does not apply. Finally, the KID includes a mandatory comprehension alert ('You are about to purchase a product that is not simple and may be difficult to understand') and targets 'informed retail investors' with 'specific knowledge', which directly confirms its complex nature under MiFID II.",
        "assessment": "Complex"
    }
}